Results 61 to 70 of about 1,527,256 (305)
Firm Size Distribution and EPL in Italy [PDF]
We study the role of employment protection legislation (EPL) in explaining the relative small average size of Italian firms. We construct a simple model that shows that the smooth relation between size and growth probability is disturbed in proximity of ...
Schivardi, Fabiano, Torrini, Roberto
core
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source
Determinants of firm-size [PDF]
Overzicht van theoretische factoren die belangrijk zijn bij het verklaren van schaalgrootte van bedrijven en verschillen in schaalgrootte tussen vergelijkbare bedrijven.
Roy Muller, Yvonne Bernardt
core
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova +14 more
wiley +1 more source
This research intends to analyze the effects of intellectual capital, debt ratio, firm size and firm growth on firm value in Indonesia. The research sample comprised 143 manufacturing firms listed on the Indonesia Stock Exchange (IDX) from the year 2017 ...
Meily Juliani, Saphira Evani
doaj
What Determines Firm Size? [PDF]
Motivated by theories of the firm, which we classify as technological' or organizational,' we analyze the determinants of firm size across industries and across countries in a sample of 15 European countries. We find that, on average, firms facing larger
Krishna B. Kumar +2 more
core
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain +10 more
wiley +1 more source
FIRM SIZE AND MONITORING [PDF]
We present a model of optimal monitoring expenditures. For any technology that yields a conventional ``S-shaped''' production function for monitoring, the optimal level of monitoring is shown to be higher in medium-sized firms than in both small and ...
Cheryl Long, Richard Boylan
core
BANK CHARACTERISTICS, FIRM CHARACTERISTICS, BANK FUNDING STRUCTURE AND BANK LENDING DURING LIQUIDITY CRISIS USING A DYNAMIC PANEL MODEL (Study on Manufacturing Firms Listed on IDX 2011 – 2014) [PDF]
This study aimed to see the behaviour of bank lending to manufacturing companies. The behaviour of bank lending is examined from the supply side, demand side and the structure of bank funding especially under a liquidity crisis. This study emphasize that
ARFINTO, Erman Denny +1 more
core
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober +16 more
wiley +1 more source

